The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Ozempic, a diabetes medication by Novo Nordisk, has gained popularity for its weight loss effects, sparking debate.

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

Weight loss drug Ozempic and type 2 diabetes jabs could be used to tackle binge drinking - Doctors and NHS England’s chief ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...